📖
mRNA-dendritic cell antigen vaccine potentiates CD38 CAR-T Cell therapy for relapsed/refractory acute myeloid leukemia.
Lu Y, Cai X, Li Y, Lv Y, Tang Y, Li Y, Zhou J, Zhang A, Gu P, Hao Z, Cui Q, Chu J, Wu D, Tang X

mRNA-dendritic cell antigen vaccine potentiates CD38 CAR-T Cell therapy for relapsed/refractory acute myeloid leukemia.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Theranostics.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title mRNA-dendritic cell antigen vaccine potentiates CD38 CAR-T Cell therapy for relapsed/refractory acute myeloid leukemia.
Author / Organization Lu Y, Cai X, Li Y, Lv Y, Tang Y, Li Y, Zhou J, Zhang A, Gu P, Hao Z, Cui Q, Chu J, Wu D, Tang X
Subject & Discipline Theranostics
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-81667
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »